Stocks
BioMarin Pharmaceutical Inc.BMRN
NASDAQHealthcareBiotechnology$58.51-0.95%
Focused on developing therapies for rare genetic diseases, this biotechnology company markets several enzyme replacement and other treatments targeting small patient populations with high unmet medical need. Its portfolio includes approved drugs for conditions such as achondroplasia and lysosomal st...
Market Cap: $11.3B52W Range: $50.76 – $73.18
Congressional Interest in BioMarin Pharmaceutical Inc. (BMRN)
10 members of Congress have disclosed 23 trades in BioMarin Pharmaceutical Inc. (BMRN), a Healthcare company. The buy/sell breakdown shows 11 purchases versus 12 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
23
Unique Politicians
10
Buys
11
Sells
12
Who in Congress Is Trading BMRN?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-03-06 | Daniel Goldman | sell | $1K – $15K |
| 2022-05-09 | Rohit Khanna | sell | $1K – $15K |